FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.

Park J, Choi Y, Ko YS, Kim Y, Pyo JS, Jang BG, Kim MA, Lee JS, Chang MS, Park JW, Lee BL
Cancer Res Treat. 2018 Jan;50(1):239-254. doi: 10.4143/crt.2016.580. Epub 2017 Mar 24. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.